Quantitative Analysis of Synthetic Magnetic Resonance Imaging in Alzheimer’s Disease

Quantitative Analysis of Synthetic Magnetic Resonance Imaging in Alzheimer’s Disease

Objectives: The purpose of this study was to evaluate the feasibility and whether synthetic MRI can benefit diagnosis of Alzheimer’s disease (AD).Materials and Methods: Eighteen patients and eighteen age-matched normal controls (NCs) underwent MR examination. The mini-mental state examination (MMSE)...

Full description

Bibliographic Details
Main Authors:	Baohui Lou, Yuwei Jiang, Chunmei Li, Pu-Yeh Wu, Shuhua Li, Bin Qin, Haibo Chen, Rui Wang, Bing Wu, Min Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Aging Neuroscience
Subjects:	CSF volume brain volume multiparametric MRI cognitive function Alzheimer’s disease neurodegenerative disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.638731/full

Similar Items

Radiomics Analysis of Magnetic Resonance Imaging Facilitates the Identification of Preclinical Alzheimer’s Disease: An Exploratory Study
by: Tao-Ran Li, et al.
Published: (2020-12-01)

Mechanistic Effects of Aerobic Exercise in Alzheimer's Disease: Imaging Findings From the Pilot FIT-AD Trial
by: Fang Yu, et al.
Published: (2021-10-01)

Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease
by: Tejas Sankar, et al.
Published: (2015-05-01)

CSF Protein Concentration Shows No Correlation With Brain Volume Measures
by: Alexander Wuschek, et al.
Published: (2019-05-01)

The choroid plexus-cerebrospinal fluid interface in Alzheimer′s disease: more than just a barrier
by: Sriram Balusu, et al.
Published: (2016-01-01)

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study
by: Anna M. Hoy, et al.
Published: (2018-07-01)

Identify the Atrophy of Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging using Morphometric MRI Analysis
by: Xiangyu Ma, et al.
Published: (2016-10-01)

Is intracranial volume a suitable proxy for brain reserve?
by: Anna Catharina van Loenhoud, et al.
Published: (2018-09-01)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
by: Claudio Liguori, et al.
Published: (2020-01-01)

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease
by: Elena Carapelle, et al.
Published: (2020-08-01)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
by: Ya-Nan Song, et al.
Published: (2019-05-01)

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
by: Chun-Chao Huang, et al.
Published: (2018-09-01)

Quantitative 3-tesla multiparametric MRI in differentiation between renal cell carcinoma subtypes
by: Ali Elsorougy, et al.
Published: (2021-02-01)

Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
by: Sunil S Adav, et al.
Published: (2019-01-01)

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
by: Tapan K. Khan
Published: (2018-04-01)

Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
by: Natalia Vilor-Tejedor, et al.
Published: (2021-08-01)

Frontal presentation of Alzheimer's disease: A series of patients with biological evidence by CSF biomarkers
by: Leonardo Cruz de Souza, et al.

Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer’s continuum
by: Jae-Won Jang, et al.
Published: (2020-01-01)

Relationship Between Exercise and Alzheimer’s Disease: A Narrative Literature Review
by: Qing Meng, et al.
Published: (2020-03-01)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
by: Erin E. Sundermann, et al.
Published: (2020-01-01)

Alzheimer’s disease: presence and role of microRNAs
by: Basavaraju Manasa, et al.
Published: (2016-08-01)

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
by: Simon Sjödin, et al.
Published: (2019-09-01)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
by: Fayçal Ben Bouallègue, et al.
Published: (2017-04-01)

Is granulovacuolar degeneration an essential pathological component of Alzheimer’s disease? A review of the pathogenesis and histochemistry of old studies
by: Maher Kurdi, et al.
Published: (2021-01-01)

Cerebral Metabolite Concentrations Are Associated With Cortical and Subcortical Volumes and Cognition in Older Adults
by: John B. Williamson, et al.
Published: (2021-02-01)

Imaging biomarkers in neurodegeneration: current and future practices
by: Peter N. E. Young, et al.
Published: (2020-04-01)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
by: Rik Ossenkoppele, et al.
Published: (2021-08-01)

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease
by: Julien Dumurgier, et al.
Published: (2013-06-01)

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
by: Dariusz Włodarek
Published: (2019-01-01)

Biomarker-based prediction of progression in MCI: Comparison of AD-signature and hippocampal volume with spinal fluid amyloid-β and tau
by: Bradford C Dickerson, et al.
Published: (2013-10-01)

Design of an Innovative Methodology for Cerebrospinal Fluid Analysis: Preliminary Results
by: Tommaso Schirinzi, et al.
Published: (2021-05-01)

Drug candidates in clinical trials for Alzheimer’s disease
by: Shih-Ya Hung, et al.
Published: (2017-07-01)

Of Mice and Men: Neurogenesis, Cognition and Alzheimer’s disease
by: Orly eLazarov, et al.
Published: (2013-08-01)

Knowledge on Alzheimer's Disease among Public Hospitals and Health Clinics Pharmacists in the State of Selangor, Malaysia
by: Thimarul Huda Mat Nuri, et al.
Published: (2017-10-01)

Alexithymia in Alzheimer’s Disease
by: Eva Mª Arroyo-Anlló, et al.
Published: (2021-12-01)

Association of impaired fasting glucose and Type 2 Diabetes Mellitus with brain volume changes in Alzheimer’s Disease patients analyzed by MRI: a retrospective study
by: Weiwei Wang, et al.
Published: (2020-08-01)

Targeting Microglial Population Dynamics in Alzheimer’s Disease: Are We Ready for a Potential Impact on Immune Function?
by: Maria Martin-Estebane, et al.
Published: (2020-06-01)

Current status of stem cell therapy for Alzheimer's disease
by: Hao-Chi Yan, et al.
Published: (2020-06-01)

Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
by: Yuan-Yuan Chen, et al.
Published: (2020-09-01)

Electrochemical Biosensors Based on Nanomaterials for Early Detection of Alzheimer’s Disease
by: Celia Toyos-Rodríguez, et al.
Published: (2020-08-01)